|1.||Centers for Disease Control and Prevention (CDC): 15 articles (10/2014 - 11/2001)|
|2.||Miller, E: 12 articles (03/2007 - 04/2000)|
|3.||Poland, Gregory A: 11 articles (10/2015 - 02/2005)|
|4.||Andrews, N: 9 articles (03/2013 - 03/2001)|
|5.||Ovsyannikova, Inna G: 8 articles (10/2015 - 02/2005)|
|6.||DeStefano, Frank: 8 articles (06/2014 - 06/2002)|
|7.||Jacobson, Robert M: 8 articles (09/2013 - 12/2002)|
|8.||Miller, Elizabeth: 8 articles (03/2011 - 02/2002)|
|9.||Taylor, B: 8 articles (03/2007 - 03/2001)|
|10.||Pankratz, V Shane: 6 articles (10/2015 - 02/2005)|
04/19/2012 - "Our study indicates that the mumps component of the MMR vaccine offered adequate protection against mumps among schoolchildren. "
05/01/2014 - "Low vaccine efficacy of mumps component among MMR vaccine recipients in Chennai, India."
01/01/2007 - "The recently observed improvement in the epidemiological situation of mumps (trend towards lower and less frequent epidemic peaks) reflect the use of measles-mumps-rubella vaccine which was increasingly acquired by parents at their own expense during the last decade. "
04/25/1998 - "The poor efficacy of the mumps component of the MMR vaccine that has mainly been used in Switzerland is also evident. "
12/01/2012 - "This is the first study to assess the impact of a third MMR vaccine dose for mumps outbreak control. "
03/01/2013 - "In Catalonia, autochthonous measles was declared eliminated in the year 2000 as the result of high measles-mumps-rubella vaccine (MMR) coverage for first and second dose (15 mo and 4 y) since the mid-1990s. "
07/01/1994 - "Measles vaccination coverage could be improved by initiating measles-mumps-rubella vaccine vaccination, routinely, at 12 months among high risk populations."
01/01/2012 - "Based on the available evidence, one MMR vaccine dose is at least 95% effective in preventing clinical measles and 92% effective in preventing secondary cases among household contacts.Effectiveness"
06/15/2011 - "A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine."
12/01/1998 - "[A seroconversion study of the measles component of the MMR vaccine in adolescents of the town of Sabrosa]."
|3.||Rubella (German Measles)
04/08/2015 - "The second dose of MMR vaccine was received by 57.2% (718/1256) of rubella-susceptible women, with the highest proportion being immigrant women compared with women born in Spain. "
04/08/2015 - "In rubella-susceptible women, two doses of MMR vaccine were recommended following birth. "
01/01/2015 - "Considerable increase in the number of rubella cases resulted from compensatory epidemic which affected mainly boys who were not inoculated with MMR vaccine. "
08/01/2014 - "Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients."
06/01/2014 - "Silent burden of rubella with serious outcomes in newborns further strengthen the case for MMR vaccine inclusion in routine immunization program of Chandigarh. "
01/01/2014 - "Due to the high prevalence of warts in various populations, we evaluated the efficacy of MMR vaccine injection in the treatment of cutaneous warts. "
06/01/2015 - "They were directly injected, without a pre-sensitization skin test, with 0.3 intralesional MMR vaccine into the largest wart at 2-week intervals until complete clearance or for a maximum of five treatments. "
10/01/2010 - "A highly significant difference was found between the therapeutic response of common warts to MMR vaccine and saline control group (P < 0.001). "
07/01/2010 - "MMR vaccine was injected into single lesions or largest wart in case of multiple lesions at 3-week intervals until complete clearance or for a maximum of 3 treatments. "
06/01/2015 - "Intralesional immunotherapy by MMR vaccine is a promising, effective, and safe treatment modality for recalcitrant warts."
|5.||Autistic Disorder (Autism)
12/08/2003 - "We will discuss the origins of the hypothesis that the MMR vaccine causes autism, studies performed to test the hypothesis, how these studies have been communicated to the public, and some suggested strategies for how this communication can be improved."
01/01/2014 - "The present study provides new epidemiologic evidence showing that African American males receiving the MMR vaccine prior to 24 months of age or 36 months of age are more likely to receive an autism diagnosis."
01/01/2014 - "The author embarked on the present study to evaluate whether a relationship exists between child age when the first MMR vaccine was administered among cases diagnosed with autism and controls born between 1986 through 1993 among school children in metropolitan Atlanta. "
08/01/2013 - "These parent accounts of perceived vaccine injury, coupled with Andrew Wakefield's fraudulent research study linking the MMR vaccine to autism, created a substantial amount of vaccine hesitancy in new parents, which manifests in both vaccine refusal and the adoption of delayed vaccine schedules. "
01/11/2012 - "A study published in 1998 linking MMR vaccine and autism was recently retracted by the Lancet because the data were falsified. "
|1.||Measles-Mumps-Rubella Vaccine (MMR Vaccine)
|3.||Chickenpox Vaccine (Vaccine, Varicella)
|4.||Immunoglobulin G (IgG)
|5.||Recurrent respiratory papillomatosis
|6.||Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)
|7.||varicella vaccine rubella mumps measles